))
Episode 18 - Issues with Treatments
Manage episode 413818591 series 3506573
Content provided by Debbie and Elyse. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Debbie and Elyse or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode, we’re talking about some issues with treatments. We’re looking at some drugs that have lost or might lose their approvals, or cases where additional measures are put in place for safety reasons.
Here are some resources or references used in the research for this episode -
Crizanlizumab statement. January 2024 » Sickle Cell Society
Crizanlizumab - end of NHS supply » Sickle Cell Society
FDA starts speedy review of Novartis’ sickle cell antibody - PMLiVE
Exa-Cel (Casgevy) Gene Therapy Update » Sickle Cell Society
Montelukast (Singulair): reminder of the risk of neuropsychiatric reactions - GOV.UK (www.gov.uk)
Remember, you can get in touch with us via clinical.research.intro@gmail.com. Please feel free to send questions, comments and compliments for Elyse to read out on the pod. It’s fun to make Debbie squirm!
Credit to our friend Sam Winnie for their awesome and cute music. Check out their work at https://www.samwinnie.com/
24 episodes
Share
